NORD Stock Forecast: Nordicus Partners Corp. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$2.80
−4.44% on the day

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 25 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$58.4M
Ticker Nerd rank
25/ 100
Median analyst target
—
Analysts covering
—
Revenue$0.0
Operating income−$1.2M
Net income−$81K
Free cash flow−$673K
Quarterly, 8 quarters to 31 Mar 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+11.6%
1M
−30.3%
YTD
−44.0%
1Y
−42.9%
From 52W high
−45.0%
From 52W low
+71.8%
$1.63
$5.09
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Nordicus Partners Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
25/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
69
Quality
50
Momentum
44
Volatility
43
Growth
37
Issuance
26
Revisions
20
Value
13

Accruals (69): Reported profit is backed by cash, and the company is not expanding recklessly.

Value (13): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

NORD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NORD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$3.00$4.00$5.00Jan 26Apr 26Jul 26Oct 26NORD

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 Apr 2017BMO CapitalDowngradeMarket Perform—
10 Jan 2017BarclaysDowngradeEqual-Weight—
13 June 2016CLSADowngradeOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

NORD appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

NORD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Nordicus Partners Corp. returned −42.9% against +6.9% for the S&P 500, dividends included.

NORD vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120Jan 26Apr 26Jul 26Oct 26NORDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NORD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
—
Price / book
0.9×

Cheaper than 74% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−8.2%

Higher than 38% of US stocks

Return on assets
−3.7%

Higher than 34% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Nordicus Partners Corp. has a market value of $58.4M and an enterprise value of $57.0M.

  • Revenue in the twelve months to 31 Mar 2026: $0.0.

  • Net income over the same four quarters: −$4.0M.

  • Free cash flow in the twelve months to 31 Mar 2026: −$4.3M.

  • Shares outstanding: 19.1M.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

NORD and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
NORDNordicus Partners Corp.$58.4M25
BOLDBoundless Bio, Inc.$54.8M93
AVXLAnavex Life Sciences Corp.$54.8M20
OKYOOKYO Pharma Ltd.$55.0M26
AZRAzora Therapeutics, Inc.$55.0M16
CHRSCoherus Oncology, Inc.$55.3M38
CGTXCognition Therapeutics, Inc.$55.4M47

Take a look at NORD’s peer groups, ranked by the model: financial stocks · biotech stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Nordicus Partners Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about NORD

How does Ticker Nerd's model rank NORD?

As at 21 Nov 2026, Nordicus Partners Corp. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Accruals (69 of 100).

What is the NORD stock forecast for 2030?

No analyst covering Nordicus Partners Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NORD are extrapolating price history, which says nothing about the business.

How has NORD stock performed over the past year?

Nordicus Partners Corp. returned -42.9% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Nordicus Partners Corp. do?

Nordicus Partners Corporation is a U.S.-based business accelerator and holding company focused on helping Nordic life sciences businesses establish and operate in the American market. Its activities combine financial consulting, commercial development, operational support, and portfolio management, connecting Nordic biomedical innovation with U.S. industry expertise and market access.

Company

About Nordicus Partners Corp.

Nordicus Partners Corporation is a U.S.-based business accelerator and holding company focused on helping Nordic life sciences businesses establish and operate in the American market. Its activities combine financial consulting, commercial development, operational support, and portfolio management, connecting Nordic biomedical innovation with U.S. industry expertise and market access. The company’s current portfolio includes Orocidin A/S and Bio-Convert A/S, preclinical biotechnology businesses developing solutions for unmet medical needs. Through these interests, Nordicus participates in the biotechnology and life sciences sectors, with exposure to research-driven products and healthcare applications. Its role extends beyond conventional consulting by supporting the identification, development, and commercialization of Nordic companies seeking a presence in the United States. Nordicus Partners Corporation therefore serves as a cross-border platform linking Scandinavian scientific enterprises with U.S. business, regulatory, and commercial resources, while maintaining a holding-company structure centered on life sciences assets and related advisory services.

CEO Mr. Henrik Rouf · United States · https://nordicuspartners.com